SPONSOR

University Hospital, Basel, Switzerland

Total Trials

Recruiting

Phases

Phase 2, Phase 1, Phase 4, Phase 2, Phase 3

Conditions studied: Idiopathic Normal Pressure Hydrocephalus (INPH)Liver Cirrhosis Multiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)Primary Progressive Multiple Sclerosis (PPMS)Arginine Vasopressin Deficiency Diabetes Insipidus Heart Failure With Reduced Ejection Fraction LSD Reaction

University Hospital, Basel, Switzerland is a clinical research sponsor with 24 registered studies on ClinicalTrials.gov, of which 24 are actively recruiting participants. Research covers conditions including Idiopathic Normal Pressure Hydrocephalus (INPH), Liver Cirrhosis, Multiple Sclerosis (MS), Relapsing-remitting Multiple Sclerosis (RRMS).

The trial portfolio spans Phase 2, Phase 1, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Basel, Switzerland

How many clinical trials has University Hospital, Basel, Switzerland sponsored?

ClinicalMetric currently tracks 24 clinical trials sponsored by University Hospital, Basel, Switzerland, of which 24 are actively recruiting participants. These trials cover conditions including Idiopathic Normal Pressure Hydrocephalus (INPH), Liver Cirrhosis, Multiple Sclerosis (MS). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Hospital, Basel, Switzerland research focus on?

University Hospital, Basel, Switzerland clinical trials span Idiopathic Normal Pressure Hydrocephalus (INPH), Liver Cirrhosis, Multiple Sclerosis (MS), Relapsing-remitting Multiple Sclerosis (RRMS), Secondary-progressive Multiple Sclerosis (SPMS), and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Hospital, Basel, Switzerland clinical trial?

To participate in a University Hospital, Basel, Switzerland trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Basel, Switzerland trials with current recruitment status updated daily.

University Hospital, Basel, Switzerland

Frequently Asked Questions — University Hospital, Basel, Switzerland

Clinical Trials by University Hospital, Basel, Switzerland

Endoscopic Third Ventriculostomy vs. Ventriculoperitoneal Shunt in Idiopathic Normal Pressure Hydrocephalus (ENDOVEST)

SASL Swiss Cirrhosis Cohort

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

Digital Solutions in Heart Therapy (DIGNITY)

Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD

Plasma Oxytocin Changes in Response to Low-dose MDMA vs. Placebo in Patients With Arginine Vasopressin Deficiency and Healthy Controls

Swiss Trauma Registry

Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness

Virtual Reality for Patient Informed Consent in Neurosurgery

Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Association of Microcirculation, Vexus Score and Femoral Vein Doppler in Patients on the ICU After Non-emergency Cardiac Surgery

The Basel CardioInsightTM - 3D Mapping Study

Swiss Itch Registry

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)

The Basel BOMP-AID Randomized Trial

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery

An Integrated Algorithm for Surgical Intervention in Chronic Lymphedema After Breast Cancer Treatment: The Basel Lymphedema Protocol

Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia

Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia

Status Epilepticus Population Study (STEPS)